Comparison of the Prognostic and Predictive Utilities of the 21-Gene Recurrence Score Assay and Adjuvant! for Women with Node-Negative, ER-Positive Breast Cancer: Results from NSABP B-14 and NSABP B-20

The Oncotype DX(®) Recurrence Score(®) (RS) is a validated genomic predictor of outcome and response to adjuvant chemotherapy in ER-positive breast cancer. Adjuvant! was developed using SEER registry data and results from the Early Breast Cancer Clinical Trialists’ overview analyses to estimate outc...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Breast Cancer Res Treat
Главные авторы: Tang, Gong, Shak, Steven, Paik, Soonmyung, Anderson, Stewart J., Costantino, Joseph P., Geyer, Charles E., Mamounas, Eleftherios P., Wickerham, D. Lawrence, Wolmark, Norman
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4266581/
https://ncbi.nlm.nih.gov/pubmed/21221771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-010-1331-z
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы